HY-100725-10mg
|
MedChemexpress LLC
|
BM212 [CAS 146204-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-100725-5mg
|
MedChemexpress LLC
|
BM212 [CAS 146204-42-4]
|
|
COVID-19-immunoregulation
|
|
HY-101040-1mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
HY-101040-10mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
HY-101040-100mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
HY-101040-5mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
HY-101040-50mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
HY-10392-10mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
HY-10392-100mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
HY-10392-25mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
HY-10392-5mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
HY-10392-50mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
HY-107775-10mg
|
MedChemexpress LLC
|
Ganfeborole (hydrochloride) [CAS 2131798-13-3]
|
|
COVID-19-immunoregulation
|
|
HY-107775-25mg
|
MedChemexpress LLC
|
Ganfeborole (hydrochloride) [CAS 2131798-13-3]
|
|
COVID-19-immunoregulation
|
|
HY-107775-5mg
|
MedChemexpress LLC
|
Ganfeborole (hydrochloride) [CAS 2131798-13-3]
|
|
COVID-19-immunoregulation
|
|
HY-107775-50mg
|
MedChemexpress LLC
|
Ganfeborole (hydrochloride) [CAS 2131798-13-3]
|
|
COVID-19-immunoregulation
|
|
HY-10844-10mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-100mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-5mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844-50mg
|
MedChemexpress LLC
|
Pretomanid [CAS 187235-37-6]
|
|
COVID-19-immunoregulation
|
|
HY-10844S-1mg
|
MedChemexpress LLC
|
Pretomanid-d4 [CAS 1346617-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-10844S-500ug
|
MedChemexpress LLC
|
Pretomanid-d4 [CAS 1346617-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-108941-1mg
|
MedChemexpress LLC
|
Salicyl-AMS [CAS 863238-55-5]
|
|
COVID-19-immunoregulation
|
|
HY-108941-10mg
|
MedChemexpress LLC
|
Salicyl-AMS [CAS 863238-55-5]
|
|
COVID-19-immunoregulation
|
|
HY-108941-100mg
|
MedChemexpress LLC
|
Salicyl-AMS [CAS 863238-55-5]
|
|
COVID-19-immunoregulation
|
|